Clinical trial · Observational
Evaluation of Prostate Cancer Margins
NCT05317143CI-TRIAL-00088315completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pathological assessment of prostate tissue
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluation of prostate cancer margins | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Positive Margin
- timeFrame
- Immediately postoperatively, expected same day as surgery
- description
- Detection of positive margin
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with prostate cancer * Subject must be scheduled for robotic-assisted radical prostatectomy at the clinical site. Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.